Jiang, K.
Cao, F.
Yin, L.
Hu, Y.
Zhao, X.
Huang, X.
Ma, X.
Li, J.
Lu, M.
Funding for this research was provided by:
Beijing Natural Science Foundation (7232018)
Beijing Natural Science Foundation (Z200015)
National Natural Foundation of China (92259302)
the Rare Tumor Research Special Project of the National Natural Science Foundation of China (82141104)
Article History
Received: 21 August 2023
Accepted: 9 November 2023
First Online: 7 December 2023
Declarations
:
: The authors have no conflicts of interest to declare.
: Human samples and clinical data were collected and used in accordance with the principles of the Declaration of Helsinki and approved by the Ethics committee of Peking University Cancer Hospital.
: All participants provided written informed consents, approval number 2023KT98.